Injection of Botulinum Toxin for Treatment of Chronic Lateral Epicondylitis: Systematic Review and Meta-Analysis

Seminars in Arthritis and Rheumatism

Volumn 40, Issue 6, 2011, Pages 532-538

  Kalichman, Leonid ^a   Bannuru, Raveendhara R ^b   Severin, Marianne ^c   Harvey, William ^b,d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TUFTS MEDICAL CENTER   (United States)

^c MACCABI HEALTHCARE SERVICES   (Israel)

^d NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

Botulinum toxin A; Lateral epicondylitis; Meta analysis; Tennis elbow; Treatment

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ARM WEAKNESS; ARTICLE; CHRONIC DISEASE; CHRONIC LATERAL EPICONDYLITIS; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; EFFECT SIZE; EXTENSOR MUSCLE; FOREARM; GRIP STRENGTH; HUMAN; INJECTION SITE PAIN; META ANALYSIS; PAIN; PARESTHESIA; PRIORITY JOURNAL; QUALITY OF LIFE; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TENNIS ELBOW;

BOTULINUM TOXINS, TYPE A; CHRONIC DISEASE; DATABASES, BIBLIOGRAPHIC; HUMANS; INJECTIONS, INTRAMUSCULAR; NEUROMUSCULAR AGENTS; OUTPATIENTS; PAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TENNIS ELBOW; TREATMENT OUTCOME;

EID: 79955971582     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2010.07.002     Document Type: Article

References (38)

1. Chiang H.C., Ko Y.C., Chen S.S., Yu H.S., Wu T.N., Chang P.Y. Prevalence of shoulder and upper-limb disorders among workers in the fish-processing industry. Scand J Work Environ Health 1993, 19:126-131.
2. Shiri R., Viikari-Juntura E., Varonen H., Heliovaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol 2006, 164:1065-1074.
3. Ranney D., Wells R., Moore A. Upper limb musculoskeletal disorders in highly repetitive industries: precise anatomical physical findings. Ergonomics 1995, 38:1408-1423.
4. Walker-Bone K., Palmer K.T., Reading I., Coggon D., Cooper C. Prevalence and impact of musculoskeletal disorders of the upper limb in the general population. Arthritis Rheum 2004, 51:642-651.
5. Hamilton P.G. The prevalence of humeral epicondylitis: a survey in general practice. J R Coll Gen Pract 1986, 36:464-465.
6. Verhaar J.A. Tennis elbow. Anatomical, epidemiological and therapeutic aspects. Int Orthop 1994, 18:263-267.
7. Struijs P.A., Kerkhoffs G.M., Assendelft W.J., Van Dijk C.N. Conservative treatment of lateral epicondylitis: brace versus physical therapy or a combination of both-a randomized clinical trial. Am J Sports Med 2004, 32:462-469.
8. Smidt N., van der Windt D.A., Assendelft W.J., Deville W.L., Korthals-de Bos I.B., Bouter L.M. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet 2002, 359:657-662.
9. Bisset L., Paungmali A., Vicenzino B., Beller E. A systematic review and meta-analysis of clinical trials on physical interventions for lateral epicondylalgia. Br J Sports Med 2005, 39:411-422. discussion 411-22.
10. de Seze M.P., de Seze M., Dehail P., Joseph P.A., Lavignolle B., Barat M., et al. [Botulinum toxin A and musculoskeletal pain]. Ann Readapt Med Phys 2003, 46:329-332.
11. Placzek R., Sohling M., Gessler M., Jerosch J. [Botulinum toxin A in orthopedic pain therapy]. Schmerz 2004, 18:498-505.
12. Keizer S.B., Rutten H.P., Pilot P., Morre H.H., v Os J.J., Verburg A.D. Botulinum toxin injection versus surgical treatment for tennis elbow: a randomized pilot study. Clin Orthop Relat Res 2002, 125-131.
13. Placzek R., Drescher W., Deuretzbacher G., Hempfing A., Meiss A.L. Treatment of chronic radial epicondylitis with botulinum toxin A. A double-blind, placebo-controlled, randomized multicenter study. J Bone Joint Surg Am 2007, 89:255-260.
14. Wong S.M., Hui A.C., Tong P.Y., Poon D.W., Yu E., Wong L.K. Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2005, 143:793-797.
15. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009, 151:W65-W94.
16. Wells G.A., Shea B., O'Connell D., Peterson J., Welch V., Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
17. Cooper H., Hedges L.V. The hand book of research synthesis 1994, Russell Sage Foundation Publications, New York (NY).
18. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
19. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
20. Wallace B.C., Schmid C.H., Lau J., Trikalinos T.A. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 2009, 9:80.
21. Guirao Cano L., Pleguezuelos Cobo E., Perez Mesquida M.E., Sanz Cartagena P. Treatment of lateral epicondylitis with botulinus toxin. Rehabilitación 2004, 38:196-198.
22. Morre H.H., Keizer S.B., van Os J.J. Treatment of chronic tennis elbow with botulinum toxin. Lancet 1997, 349:1746.
23. Zhu Z., Chen W.F., Lin L., Chen H.X. [Botulinum toxin A for the treatment of refractory external humeral epicondylitis: a report of 58 cases]. Zhongguo Gu Shang 2008, 21:465-466.
24. Oskarsson E., Piehl Aulin K., Gustafsson B.E., Pettersson K. Improved intramuscular blood flow and normalized metabolism in lateral epicondylitis after botulinum toxin treatment. Scand J Med Sci Sports 2009, 19:323-328.
25. Placzek R., Lindner M.S., Deuretzbacher G., Meiss A.L. [Therapy for chronic radial epicondylitis with botulinum toxin A]. Z Orthop Ihre Grenzgeb 2004, 142:701-705.
26. Espandar R., Heidari P., Rasouli M.R., Saadat S., Farzan M., Rostami M., et al. Use of anatomic measurement to guide injection of botulinum toxin for the management of chronic lateral epicondylitis: a randomized controlled trial. CMAJ 2010, 182:768-773.
27. Hayton M.J., Santini A.J., Hughes P.J., Frostick S.P., Trail I.A., Stanley J.K. Botulinum toxin injection in the treatment of tennis elbow. A double-blind, randomized, controlled, pilot study. J Bone Joint Surg Am 2005, 87:503-507.
28. Bluthner M., Haugke C., Kalischewski P. Treatment of lateral epicondylitis elbow with botulinum toxin A-a first experience. Arch Pharmacol 2002, 365(Suppl 2). R14-ABS-1147.
29. Desrosiers J., Hebert R., Bravo G., Dutil E. Comparison of the Jamar dynamometer and the Martin vigorimeter for grip strength measurements in a healthy elderly population. Scand J Rehabil Med 1995, 27:137-143.
30. Cohen J. Statistical power analysis for the behavioral sciences 1988, Lawrence Erlbaum Associates, Hillsdale (NJ). 2nd ed.
31. De Andres J., Cerda-Olmedo G., Valia J.C., Monsalve V., Lopez A., Minguez A. Use of botulinum toxin in the treatment of chronic myofascial pain. Clin J Pain 2003, 19:269-275.
32. Papapetropoulos S., Singer C. Botulinum toxin in movement disorders. Semin Neurol 2007, 27:183-194.
33. Kuan T.S., Chen J.T., Chen S.M., Chien C.H., Hong C.Z. Effect of botulinum toxin on endplate noise in myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil 2002, 81:512-520. quiz 521-3.
34. Guyer B.M. Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999, 3:427-431.
35. Voller B., Sycha T., Gustorff B., Schmetterer L., Lehr S., Eichler H.G., et al. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A. Neurology 2003, 61:940-944.
36. Fernandez-Carnero J., Fernandez-de-las-Penas C., de la Llave-Rincon A.I., Ge H.Y., Arendt-Nielsen L. Bilateral myofascial trigger points in the forearm muscles in patients with chronic unilateral lateral epicondylalgia: a blinded, controlled study. Clin J Pain 2008, 24:802-807.
37. Kamanli A., Kaya A., Ardicoglu O., Ozgocmen S., Zengin F.O., Bayik Y. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 2005, 25:604-611.
38. Naumann M., Albanese A., Heinen F., Molenaers G., Relja M. Safety and efficacy of botulinum toxin type A following long-term use. Eur J Neurol 2006, 13(Suppl 4):35-40.